Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
DOMA Acquires MPA Services, Expanding I/DD Platform in Ohio
DOMA has acquired MPA Services, an intellectual and developmental disabilities (I/DD) provider headquartered in Sidney, Ohio. Founded in 2003, MPA Services specializes in unlocking the potential of individuals with disabilities by providing community support, daily living assistance and adult day programs across several Ohio counties (Allen, Auglaize, Mercer, Darke, Miami, Shelby and Logan counties). Based in Minneapolis, Minnesota, DOMA is a healthcare and human services organization that specializes in community living and support services for individuals with intellectual and developmental disabilities. Agenda Health acted as exclusive sell-side advisor to MPA Services. The Austin,... Read More »
Ascension Narrows Operating Losses as Revenue and Patient Volumes Improve in FY26 Q3
Ascension, one of the nation’s largest nonprofit Catholic health systems, reported improved operating performance for the nine months ended March 31, 2026, as same-facility revenue growth and stabilizing patient volumes helped narrow operating losses. The health system posted a recurring operating loss of $166 million, compared with a $381 million loss during the same period in fiscal 2025, while recurring operating margin improved to negative 0.9% from negative 2.0%. Net income excluding noncontrolling interests reached $621 million for the period. Ascension said its same-facility total operating revenue increased by $1.5 billion, or 9.3%, year over year, driven by higher net patient... Read More »
InSphero Acquires PhenoVista Biosciences to Expand 3D Cell Assay Capabilities
InSphero AG has acquired PhenoVista Biosciences, Inc., a San Diego-based provider of high-content imaging and phenotypic assay services. The deal combines PhenoVista’s expertise in imaging-based assay development and cell painting with InSphero’s leadership in scalable 3D microtissue models and microphysiological systems. Financial terms were not disclosed. PhenoVista Biosciences is a contract research organization (CRO) that develops and executes disease-relevant, cell-based assays for biopharmaceutical clients of all stages and sizes using advanced cell models combined with high-content imaging and sophisticated data-analysis capabilities. Based in Switzerland, InSphero AG is a global... Read More »
Innovaccer Buys CaduceusHealth in Asset Deal to Automate Revenue Cycle
Innovaccer Inc. has acquired the assets of CaduceusHealth, a revenue cycle management (RCM) services provider, to expand its Flow suite into full end-to-end revenue cycle operations for ambulatory care. The deal creates what Innovaccer describes as the first AI-native platform unifying scheduling, patient engagement and complete RCM in a single layer. Financial terms were not disclosed. Founded in 1997, CaduceusHealth manages provider billing, claims and denial resolution across thousands of practices, dozens of specialties,and major electronic health record systems. The company’s U.S.-based team serves nearly 4,000 providers and handles approximately $5 billion in gross patient charges... Read More »
Clutch Health Acquires Perx Health’s U.S. Business
Clutch has acquired Perx Health’s U.S. operations, expanding its AI-powered Clutch Health platform with clinically validated behavioral engagement technology. The deal adds gamification, personalized incentives and real-time nudges designed to improve medication adherence, chronic condition management and treatment plan completion. Financial terms were not disclosed. Perx Health’s mobile platform has achieved medication adherence rates of 80-85% and strong engagement among complex patients managing multiple chronic conditions. It supports flexible task-based programs, configurable rewards, biometric tracking and enterprise reporting. The acquisition follows Clutch’s 2025 purchase of... Read More »
GHO Capital, CBC Create $15B Healthcare Investment Firm
GHO Capital and CBC Group agreed to combine their healthcare investment platforms to create what the firms said will be the world’s largest dedicated healthcare investment firm. The combined organization is expected to manage approximately $15 billion in assets focused exclusively on healthcare investments across Europe, North America and Asia. Financial terms of the transaction were not disclosed. London-based GHO Capital is a healthcare-focused private equity firm investing across pharma services, medtech, healthcare services and specialty pharmaceuticals, while Singapore-headquartered CBC Group is an investment platform focused on healthcare, biotech and life sciences. The firms said... Read More »
Lilly Picks Up Engage Bio to Bolster Non-Viral Genetic Medicines Platform
Lilly (formerly known as Eli Lilly and Company) has acquired Engage Biologics Inc., a San Carlos, California-based preclinical biotechnology company developing the Tethosome™ platform for non-viral DNA delivery. The deal is valued at up to $202 million in cash, including an upfront payment and development milestone payments. An upfront purchase price was not disclosed. Engage Bio’s Tethosome platform combines engineered DNA payloads with lipid nanoparticle delivery and an mRNA-encoded proprietary protein to improve nuclear localization, expression, potency, tolerability, and redosability of non-viral DNA therapies. The technology targets limitations in current non-viral approaches while... Read More »
Everis Medical Buys Hood Laboratories
Everis Medical has acquired Hood Laboratories, a Pembroke, Massachusetts-based manufacturer of ear, nose and throat, airway and thoracic devices. The deal expands Everis’ portfolio in otolaryngology/head and neck surgery and strengthens its position in airway management. Hood Laboratories, founded in 1962, will continue operations with seamless product availability for customers. Financial terms were not disclosed. Hood Laboratories is a supplier of specialized devices including tracheal T-Tubes, bronchial and tracheal stents, nasal splints and products for rhinology, laryngology, interventional pulmonology and speech therapy. Everis Medical, headquartered in Kalamazoo, Michigan and backed... Read More »
MB2 Dental Announces New Partnership with Mendota Dental Associates
MB2 Dental Solutions announced a new partnership with Mendota Dental Associates, further expanding the dental partnership organization’s presence in the Midwest. Financial terms of the transaction were not disclosed. Mendota Dental Associates provides general dentistry services and will continue operating under its established local brand following the partnership. It is based in Mendota Heights, Minnesota. MB2 Dental Solutions, a portfolio company of middle-market private equity firm Charlesbank Capital Partners since February 2021, partners with dentists and specialists. It supports more than 1,900 physicians. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
